Previous Article | Next Article 
Molecular and Cellular Biology, October 2000, p. 7192-7204, Vol. 20, No. 19
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Amino Acids Control Mammalian Gene Transcription: Activating
Transcription Factor 2 Is Essential for the Amino Acid
Responsiveness of the CHOP Promoter
Alain
Bruhat,1
Céline
Jousse,1
Valérie
Carraro,1
Andreas
M.
Reimold,2
Marc
Ferrara,1 and
Pierre
Fafournoux1,*
U.R. 238 de Nutrition Cellulaire et
Moléculaire, INRA de Theix, 63122 Saint Genès Champanelle,
France,1 and Department of
Immunology and Infectious Diseases, Harvard School of Public Health,
and Department of Medicine, Harvard Medical School, Boston,
Massachusetts 021152
Received 31 January 2000/Returned for modification 2 March
2000/Accepted 7 July 2000
 |
ABSTRACT |
In mammals, plasma concentration of amino acids is affected by
nutritional or pathological conditions. It has been well
established that nutrients, and particularly amino acids, are involved
in the control of gene expression. Here we
examined the molecular mechanisms involved in the regulation of
CHOP (a CCAAT/enhancer-binding protein
[C/EBP]-related gene) expression upon amino acid limitation. We have
previously shown that regulation of CHOP mRNA expression by
amino acid concentration has both transcriptional and
posttranscriptional components. We report the analysis of
cis- and trans-acting elements involved in the
transcriptional activation of the human CHOP
gene by leucine starvation. Using a transient expression assay, we show
that a cis-positive element is essential for amino acid
regulation of the CHOP promoter. This sequence is the
first described that can regulate a basal promoter in response
to starvation for several individual amino acids and
therefore can be called an amino acid response element (AARE).
In addition, we show that the CHOP AARE is
related to C/EBP and ATF/CRE binding sites and binds in vitro the activating transcription factor 2 (ATF-2) in starved and
unstarved conditions. Using ATF-2-deficient mouse embryonic
fibroblasts and an ATF-2-dominant negative mutant, we demonstrate that
expression of this transcription factor is essential for the
transcriptional activation of CHOP by leucine starvation.
Altogether, these results suggest that ATF-2 may be a member
of a cascade of molecular events by which the cellular
concentration of amino acids can regulate mammalian gene expression.
 |
INTRODUCTION |
The control of gene expression in
multicellular organisms differs in many aspects from that operating in
single-cell organisms and involves complex interactions of hormonal,
neuronal, and nutritional factors. Although not as widely appreciated
as the other factors, nutritional and metabolic signals play an
important role in controlling gene expression in mammalian cells. It
has been shown that major (carbohydrates, fatty acids, and sterols) or
minor (minerals and vitamins) dietary constituents participate in the
regulation of gene expression in response to nutritional changes
(16, 20, 54, 60). Much less is known about the role of amino
acids in the control of gene expression. The relative
concentrations of amino acids are altered in response to various forms
of stresses, such as sepsis, fevers, thermal burns, or malnutrition.
For example, alteration of the amino acid concentration has been
reported when there is a deficiency of any one of the essential amino
acids, a dietary imbalance of amino acids, or an insufficient intake of
protein (3).
The molecular mechanisms involved in the control of gene expression in
response to amino acid availability have been extensively studied in
yeast (24). In addition to specific controls of genes involved in the synthesis of individual amino acids, the yeast employs
a general control process whereby multiple genes in nine different
biosynthetic pathways are regulated by starvation of the cell for a
single amino acid (25, 26). In mammalian cells, a few
examples of enzymes, transporters, and mRNAs that are regulated by amino acid availability have been reported (32, 35). At the molecular level, the current understanding of amino acid-dependent control of gene expression is limited. It was reported that
up-regulation of asparagine synthetase mRNA in response to amino acid
limitation involves both transcriptional and posttranscriptional
components (18). These authors defined a region of the
asparagine synthetase promoter involved in transcriptional regulation
in response to amino acid starvation but did not demonstrate transfer
of amino acid responsiveness to a heterologous promoter.
Among the amino acid-regulated genes in mammalian cells,
CHOP (also called GADD153) expression exhibits
the greatest induction level (40). CHOP encodes a
small nuclear protein that regulates certain aspects of the cell
response to stress (62, 65). The induction of
CHOP expression by stress agents is generally linked to
the activation of an endoplasmic reticulum stress (ER stress), manifested as the accumulation of malfolded proteins in the
endoplasmic reticulum (unfolded protein response) (61,
65). CHOP protein belongs to the CCAAT/enhancer-binding protein
(C/EBP) family of transcription factors that have been implicated in
the regulation of processes relevant to energy metabolism
(43), cellular proliferation, and differentiation and
expression of cell type-specific genes (7, 9, 56). By
forming heterodimers with the members of the C/EBP family, CHOP protein
can influence gene expression both as a dominant negative regulator of
C/EBP binding to one class of DNA targets and by directing CHOP-C/EBP
heterodimers to other sequences (5, 6, 14, 51, 55, 62).
It has been shown previously that leucine limitation in human cell
lines leads to induction of CHOP mRNA and protein in a dose-dependent
manner (8). In addition, the regulation of CHOP mRNA expression by leucine has both transcriptional and
posttranscriptional components (8). The signaling pathway
that links amino acid deprivation to CHOP expression is not
known. However, it has been demonstrated that amino acid starvation
regulates the expression of CHOP through a specific pathway
that is distinct from the ER stress signaling cascade (31).
In the present study, we report the characterization of cis-
and trans-acting elements involved in the transcriptional
activation of CHOP by amino acid deprivation. By deletion
and mutation analysis of the CHOP promoter region, we
characterize an amino acid response element (AARE). In addition, we
show that the AARE binds activating transcription factor 2 in vitro and
that this transcription factor is essential for the transcriptional
activation of CHOP by leucine starvation.
 |
MATERIALS AND METHODS |
Cell culture and treatment conditions.
Cells were cultured
at 37°C in Dulbecco's modified Eagle's medium F12 (DMEM F12)
(Sigma) containing 10% (mouse embryonic fibroblasts [MEF], HeLa, and
HepG2) or 20% (Caco-2) fetal bovine serum. When indicated, DMEM F12
lacking leucine was used. For other amino acid starvation experiments,
MEM medium (Life Technologies, Inc.) was used. In all experiments
involving amino acid starvation, 10% dialyzed calf serum was used. MEF
deficient in C/EBP
were a gift of David Ron (65). MEF
deficient in ATF-2 were produced from decapitated, eviscerated day 14.5 ATF-20/0 embryos (39) using a 3T3 protocol until
cells passed through crisis, typically by passage 18 (53).
DNA transfection and luciferase assay.
Cells were plated in
12-well dishes and transfected by the calcium phosphate coprecipitation
method as described previously (8). Two micrograms of
luciferase plasmid was transfected into the cells along with 0.1 µg
of pCMV-
Gal, a plasmid carrying the bacterial
-galactosidase gene
fused to the human cytomegalovirus immediate-early enhancer-promoter
region, as an internal control. In the experiments using cDNA
expression plasmids, a mixture containing 1 µg of luciferase plasmid,
1 µg of cDNA expression plasmid, and 0.05 µg of pCMV-
Gal was
transfected in the cells. The total amount of plasmid DNA was adjusted
to 2 µg by the addition of the control plasmid lacking the cDNA to be
expressed. Cells were then exposed to the precipitate for 16 h,
washed twice in phosphate-buffered saline (PBS), and then incubated
with DMEM F12 containing 10% calf serum. Twenty-four hours after
transfection, cells were starved for 16 h. After starvation, cells
were harvested in 150 µl of lysis buffer (Promega) and centrifuged at
13,000 × g for 2 min. Twenty microliters of the
supernatant was assayed for luciferase activity (PRODEMAT, Anduze,
France).
-Galactosidase activity was measured as described
previously (23). Relative luciferase activity was given as
the ratio of relative light units to relative
-galactosidase units.
All values are the means calculated from the results of at least three
independent experiments.
RNA isolation and Northern blot analysis.
Total RNA was
prepared as previously described (12). Northern blots were
performed according to the procedure of Sambrook et al.
(48). The membranes were UV cross-linked, and then
prehybridization was carried out for 2 h at 55°C in 50%
formamide-6× SSC (1× SSC is 0.15 M NaCl plus 0.015 M sodium
citrate)-5× Denhardt's reagent-0.5% sodium dodecyl sulfate
(SDS)-0.1 mg of sonicated salmon sperm DNA/ml-10 µg of yeast
tRNA/ml. The human CHOP cDNA (BH1), generously provided by
N. J. Holbrook (46), was used as a probe. BH1 plasmid was linearized by PstI, and 32P-riboprobes were
synthesized (48) using T7 RNA polymerase (Promega). Hybridization was carried out for 16 h at 55°C. The membranes were washed for 15 min at 55°C successively in 2× SSC containing 0.1% SDS, 0.5× SSC containing 0.1% SDS, and 0.1× SSC containing 0.1% SDS. Labeled bands were detected by autoradiography.
Autoradiogram signals were visualized by using a PhosphorImager and
IMAGEQUANT software (Molecular Dynamics). To control for variation in
either the amount of RNA in different samples or loading errors, all blots were rehybridized with a DNA probe corresponding to
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA. Relative
CHOP mRNA was determined as the ratio of CHOP
mRNA to GAPDH mRNA.
Antibodies.
Anti-C/EBP
serum was generously provided by
U. Schiebler. Anti-ATF-4 serum was a gift from D. Ron. Anti-ATF-1
(catalog number sc-241X), anti-ATF-2 (catalog number sc-6233X),
anti-ATF-3 (catalog number sc-188X), and anti-c-Jun (catalog number
sc-1694X) were purchased from Santa Cruz Biotechnologies.
Nuclear extract preparation.
Nuclear extracts were prepared
from HeLa cells plated in 150-mm-diameter dishes. Cells were washed
twice with ice-cold PBS, harvested with a rubber policeman, and
centrifuged at 4°C. Cell pellets were resuspended in 10 volumes of
ice-cold lysis buffer (20 mM HEPES [pH 7.9], 10 mM KCl, 3 mM
MgCl2, 0.5 mM EDTA, 1 mM dithiothreitol [DTT], 0.5 mM
phenylmethylsulfonyl fluoride [PMSF], 1 µg of leupeptin/ml),
incubated on ice for 5 min, and centrifuged 5 min at 2,000 × g. Nuclear pellets were resuspended in 2 volumes of ice-cold
extract buffer (20 mM HEPES [pH 7.9], 450 mM KCl, 3 mM
MgCl2, 0.5 mM EDTA, 25% glycerol, 1 mM DTT, 1 mM PMSF, 1 µg of leupeptin/ml, 0.5 mM spermidine, 0.15 mM spermine) and
incubated on ice for 30 min. After centrifugation for 10 min at
14,000 × g, the supernatant was dialyzed for two 2-h
periods against 100 volumes of dialysis buffer (20 mM HEPES [pH 7.9],
50 mM KCl, 0.2 mM EDTA, 10% glycerol, 1 mM DTT, 0.5 mM PMSF), frozen,
and stored at
80°C.
Oligonucleotides.
Oligonucleotides were from Eurogentec.
When double-stranded oligonucleotides were required, equal numbers of
moles of complementary strands were heated to 90°C for 1 min and
annealed by slow cooling to room temperature.
Gel mobility shift assays.
Probes for the gel mobility shift
assay were obtained by labeling synthetic double-stranded
oligonucleotides with T4 polynucleotide kinase (Eurogentec). HeLa
nuclear extracts (5 µg) were preincubated for 10 min on ice in the
presence of 3 µg of poly(dI-dC) in a reaction mixture containing 25 mM HEPES (pH 7.9), 60 mM KCl, 2.5 mM MgCl2, 0.1 mM EDTA,
0.75 mM DTT, 1 mM PMSF, and 5% glycerol. Fifty femtomoles (i.e.,
100,000 cpm) of end-labeled oligonucleotides was then added and
incubated for a further 10 min. Competition for specific complex
formation was performed by preincubation of the extract with a 25-, 50-, or 100-fold molar excess of the unlabeled competitors. To test the
effect of specific antibodies, 1 µl of antiserum (see above) was
added to the incubation mixture on ice 2 h prior to the addition
of the labeled probe. The samples were loaded onto a prerun,
16-cm-long, 1.5-mm-thick 4% acrylamide-bisacrylamide (29:1) gel,
prepared in 1× TGE (25 mM Tris base, 190 mM glycine, 1 mM EDTA [pH
8.5]). Electrophoresis was carried out at 240 V in 1× TGE for 2 h at 4°C. Radioactive bands were visualized by using a PhosphorImager
and IMAGEQUANT software (Molecular Dynamics). Each mobility shift
experiment was repeated three times to confirm the reproducibility of
the results.
Plasmid constructions.
All constructs containing deletions
in the CHOP promoter were generated by PCR from cloned
genomic DNA, using Pfu polymerase (Stratagene), primers, and
antisense primers containing appropriate restriction sites at their 5'
end. Amplified fragments were then cloned into the pGL3-basic reporter
construct (Promega) using the corresponding restriction sites. For 5'
CHOP promoter deletions (pCHOP-LUC series [see
Fig. 1]), XhoI-ended primers and
HindIII-ended antisense primers were used. For internal
CHOP promoter deletions (pCHOP-LUC
series
[see Fig. 2]), fragments of the 5' part of the CHOP
promoter were generated by using SstI-ended primers and MluI-ended antisense primers and fragments of the 3'
part by using XhoI-ended primers and
HindIII-ended antisense primers.
The 5' mutant promoter constructs (pCHOP-LUC-mt
series [see Fig. 2C]) were generated by inserting wild-type or
mutated oligonucleotides (
318 to
286; double-stranded form with
MluI-XhoI-compatible ends [see Fig. 2B])
between the MluI and XhoI sites in the
pCHOP-LUC
318/
286 plasmid. Mutations in the 5'
CHOP sequence were made by substituting TAGA for GCCC
(SP-1 mutant) or CAGATC for ATTGCA (C/EBP-ATF
mutant) in both the sense and antisense orientations to create
pCHOP-LUC-mt1 and
pCHOP-LUC-mt2 constructs, respectively.
TATATK-LUC plasmid containing the minimal herpes simplex
virus promoter for thymidine kinase (
40 to +50) was generated by PCR
from cloned genomic DNA, using XhoI-ended primers and
HindIII-ended antisense primers. The amplified fragment
was then cloned into pGL3 using the XhoI and
HindIII restriction sites. The
1XAARECHOP-TATATK-LUC mutant series was made by
inserting wild-type or mutated oligonucleotides (
313 to
295;
double-stranded form with
SstI-XhoI-compatible ends [see Fig. 4A])
between the SstI and XhoI sites of
TATATK-LUC plasmid. The mutation series in the
CHOP AARE sequence was made by substituting CCT for AAC
(mt3), CAG for ATT (mt4), ATG for GCA
(mt5), GAC for TCA (mt6), GAA for TCC
(mt7), AAT for CCG (mt8), and CTTATTGCATCATCCCCGC
for AACATTGCATCAGAAAATC (mt9) in both the sense
and antisense orientation. Plasmid
2XCHOPAARE-TATATK-LUC was constructed by
inserting SstI-XhoI double-stranded
oligonucleotides containing two iterations of the
CHOP AARE sequence into TATATK-LUC plasmid.
2XC/EBP-TATATK-LUC, 2XFNCRE-TATATK-LUC,
2Xjun2TRE-TATATK-LUC, 2XE4ATF-TATATK-LUC, and
2XC/EBP-CRE-TATATK-LUC plasmids were constructed by
inserting SstI-XhoI double-stranded
oligonucleotides containing two iterations of the corresponding
sequence (see Fig. 5A) into the SstI and XhoI
sites of TATATK-LUC. All the luciferase plasmid constructs
were sequenced before utilization using the U.S. Biochemicals Sequenase
sequencing kit according to the manufacturer's instructions. Plasmids
to express ATF-2 and the ATF-2Ala dominant negative mutant (see Fig.
9B) containing the chicken cytoplasmic
-actin promoter were a gift
of S. Ishii (41, 49).
 |
RESULTS |
Transcriptional activation of CHOP by leucine
starvation requires sequences located upstream from the start
site.
To understand the regulation of gene expression by amino
acids at a molecular level, we have studied the regulation of
CHOP expression in response to leucine limitation because
(i) leucine is an essential amino acid that is poorly utilized by
HeLa cells during a 16-h incubation period (data not shown),
and (ii) leucine, which is transported by system L, is rapidly
equilibrated through the cell membrane (34, 42). It has been
shown previously that regulation of CHOP transcription by
leucine starvation is mediated through the promoter sequence situated
between nucleotide position
954 and +91 (8). To identify
amino acid-responsive elements within the CHOP promoter, a
series of deletions in this region was created by PCR and fused to the
coding region of the luciferase (LUC) reporter gene (Fig.
1). These constructs were transiently transfected into HeLa cells, and the response to leucine was determined by LUC assay, in starved and nonstarved conditions. Deletion to
649
had no significant effect on the activation of the CHOP
promoter by leucine starvation (row 2). By contrast, deletion from
280 decreased the amino acid inducibility, suggesting that the region between
649 and
280 contains cis-positive elements
involved in the transcriptional activation of CHOP by
leucine starvation (row 3). Further deletions of the promoter from
221 to
40 resulted in a similar fold reduction in amino acid
responsiveness and a progressive reduction of basal LUC activities
(rows 4 to 6).

View larger version (10K):
[in this window]
[in a new window]
|
FIG. 1.
Effect of leucine limitation on 5' deletions of the
CHOP promoter. HeLa cells were transiently transfected with
LUC constructs containing progressive 5' deletions of the
CHOP promoter, as described in Materials and Methods.
Twenty-four hours after transfection, cells were incubated for 16 h in DMEM F12 (420 µM leucine) or in DMEM F12 lacking leucine (0 µM
leucine) and then were harvested for preparation of cell extracts and
determination of LUC activity. Relative LUC activities were determined
as described in Materials and Methods. The relative fold induction,
defined as the ratio of the relative LUC activity of leucine-starved
cells to unstarved cells, is indicated in parentheses to the right of
the bars.
|
|
Localization of an upstream positive element involved in activation
of CHOP transcription by leucine starvation.
To
localize the positive elements involved in activation of
CHOP transcription by leucine starvation, HeLa cells were
transfected with a series of constructs containing internal deletions
of the CHOP promoter (Fig.
2A). These deletions can be divided into
two groups according to their level of amino acid inducibility. The first group includes three deletions that produced high levels of amino
acid inducibility (rows 2, 4, and 5), while the second group of
deletions led to reduced levels of induction (rows 3, 6, 7, and 8).
These findings demonstrate that a 33-bp CHOP promoter region
from
318 to
286 contains a cis-positive element that is
essential for amino acid regulation. Close inspection of this 33-bp
promoter sequence reveals the presence of a site that is similar to
both the C/EBP consensus and the ATF/CRE-like sequence (referred to as
a C/EBP-ATF composite site [15, 63]) and the presence
of a putative SP-1 binding site (Fig. 2B). To determine the importance
of each site in the leucine responsiveness of the CHOP
promoter, we mutated these sites and assayed the LUC activity of the
constructs. Figure 2C shows that mutation of the C/EBP-ATF site
resulted in a decrease of amino acid responsiveness (row 11), while
mutations in the SP-1 site did not affect the activation of the
CHOP promoter by leucine starvation (row 10). These results show that the C/EBP-ATF composite site is essential for transcriptional activation of CHOP in response to leucine starvation.

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 2.
Identification of an upstream cis-positive
element involved in the activation of CHOP transcription by
leucine starvation. HeLa cells were transiently transfected with LUC
constructs containing internal 5' deletions (A) or 5' mutations (C) of
the CHOP promoter as described in Materials and Methods. The
experiments were carried out as described in the legend to Fig. 1. The
relative fold induction, defined as the ratio of the relative LUC
activity of leucine-starved cells to unstarved cells, is indicated in
parentheses to the right of the bars. (B) Nucleotide sequence from
318 to 286 relative to the start site of CHOP
transcription. The positions of the SP-1 and composite C/EBP-ATF sites
are indicated. The open circles represent the positions of substitution
mutations in either the SP-1 site or the C/EBP-ATF site.
|
|
The cis-positive element in the CHOP
promoter is an AARE.
To determine whether the above-described
CHOP cis-positive element could, by itself, render a
heterologous promoter amino acid responsive, one or two copies
of a 19-bp segment of the CHOP promoter from
313 to
295
containing the positive element were cloned 5' of the minimal herpes
simplex virus promoter for thymidine kinase (TK). As shown in Fig.
3A, a single copy of the
CHOP-positive sequence was able to regulate the basal
promoter in response to leucine (row 2). Furthermore, the leucine
starvation-induced activity was enhanced synergistically by the
presence of two copies of the positive element in the promoter (row 3).

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 3.
The cis-positive element is an AARE. (A) HeLa
cells were transfected with LUC constructs containing a single or two
copies of a 19-bp segment of the CHOP promoter including the
positive element ( 313 to 295) inserted 5' to the TK promoter. The
19-bp segment of the CHOP promoter is indicated by a black
diamond. Twenty-four hours after transfection, cells were incubated for
16 h in DMEM F12 (420 µM leucine) or in DMEM F12 lacking leucine
(0 µM leucine) and then were harvested for preparation of cell
extracts and determination of LUC activity. (B) HeLa, HepG2, and Caco-2
cells were transfected with LUC constructs containing two copies of the
19-bp segment of the CHOP promoter including the positive
element ( 313 to 295) inserted 5' to the TK promoter. Twenty-four
hours after transfection, cells were incubated for 16 h in MEM
control medium (MEM) or in MEM lacking one amino acid (MEM-AA) and then
were harvested for preparation of cell extracts and determination of
LUC activity. Relative LUC activities were determined as described in
Materials and Methods. (A) The relative fold induction, defined as the
ratio of the relative LUC activity of leucine-starved cells to
unstarved cells, is indicated in parentheses to the right of the
bars.
|
|
Starvation of other amino acids was tested for its ability to influence
LUC activity driven by two copies of the CHOP-positive element (from
313 to
295) in front of the minimal TK promoter (Fig.
3B). The most potent omission of an amino acid for increasing the LUC
activity level appeared to be that of methionine, arginine, lysine, or
leucine. Deprivation of phenylalanine, histidine, alanine, and cysteine
resulted in less dramatic but consistent increases of LUC activity. In
contrast, proline, aspartate, and glutamate had no significant effects
on the level of LUC activity. These results demonstrate that two copies
of the CHOP-positive sequence can regulate a basal promoter
in response to the omission of several individual amino acids. The
extent of induction varied significantly according to the amino acid
omitted, although only 3 of 11 amino acids tested had no effect. Fig.
3B also shows that the CHOP-positive sequence is functional
in other human cell types, such as HepG2 and Caco-2, in which the
CHOP gene is also regulated by amino acid starvation
(8). Altogether these results demonstrate that the upstream
positive element in the CHOP promoter can be considered an AARE.
The minimum AARE core sequence is 5'-ATTGCATCA-3'.
To pinpoint the exact nucleotides of the CHOP AARE
that are involved in amino acid regulation, we scanned the
313 to
295 promoter region by site-directed mutagenesis. Each mutation
consisted of a 3-bp substitution in a context of a single copy of the
CHOP AARE sequence inserted upstream of the TK promoter
(Fig. 4A). Mutations mt3 and
mt8 did not affect the activation of the TK promoter
construct by leucine starvation, and mutation mt7 caused a
slight decrease in amino acid responsiveness. By contrast, mutations mt4, mt5, and mt6 resulted in a
complete loss of the amino acid inducibility, suggesting that nine
nucleotides are essential for conferring amino acid sensitivity.
Furthermore, mutation mt9 demonstrates that the minimum core
sequence able to render a promoter amino acid responsive is
5'-ATTGCATCA-3'.

View larger version (51K):
[in this window]
[in a new window]
|
FIG. 4.
Identification of a CHOP AARE core sequence.
(A) HeLa cells were transfected with LUC constructs containing a single
copy of native or mutant CHOP AARE ( 313 to 295) inserted
5' to the TK promoter. The open circles represent the positions of
substitution mutations in the 19-bp CHOP AARE sequence. The
minimum AARE core sequence is shown in bold letters. Twenty-four hours
after transfection, cells were incubated for 16 h in DMEM F12 (420 µM leucine) or in DMEM F12 lacking leucine (0 µM leucine) and then
were harvested for preparation of cell extracts and determination of
LUC activity. Relative LUC activities were determined as described in
Materials and Methods. The relative fold induction, defined as the
ratio of the relative LUC activity of leucine-starved cells to
unstarved cells, is indicated in parentheses. Each data point
represents the mean of at least three independent experiments performed
in triplicate. (B) Gel mobility shift assays of nuclear extracts from
HeLa cells incubated for 16 h in DMEM F12 (420 µM leucine) or in
DMEM F12 lacking leucine (0 µM leucine) in the presence of the 19-bp
CHOP AARE probe. The AARE probe carried sequences 313 to
295 (wild type). The 19-bp CHOP AARE and different mutated
AARE oligonucleotides (mt3 to 8) were used as
competitors at a 25- or 50-fold molar excess relative to the probe. The
specific DNA-protein complex is indicated by an arrow.
|
|
To investigate whether the minimum core DNA sequence of the
AARE mediated the regulation of the CHOP promoter through
the binding of protein(s), gel mobility shift assays were
performed with a 19-bp double-stranded probe (CHOP AARE)
containing sequences
313 to
295 of the CHOP
promoter (Fig. 4B). A major specific DNA-protein complex
was detected after incubation of nonstarved HeLa nuclear extracts with
the 32P-labeled CHOP AARE probe (lane 1). The
abundance of this protein complex did not vary following leucine
starvation (compare lanes 16 and 17). To identify the minimum sequence
within the AARE that was capable of binding the proteins producing the
gel retardation band, we introduced the substitution mutations
described above in the 19-bp double-stranded oligonucleotide (see Fig.
4A) and performed gel mobility shift competition assays. The
DNA-protein complex was highly competed by an excess of cold
mt3 (Fig. 4B, lanes 4 and 5) and mt8 (lanes 14 and 15) mutated oligonucleotides, more weakly competed by
mt5 (lanes 8 and 9) and mt7 (lanes 12 and 13)
mutated oligonucleotides, and not competed by an equal amount of
mt4 (lanes 6 and 7) and mt6 (lanes 10 and 11)
oligonucleotides. Moreover, the DNA-protein complex failed to form when
mt4, mt5, and mt6 mutated
oligonucleotides were used as a probe (data not shown). These results
demonstrate that the minimum sequence capable of binding proteins
producing the gel retardation band corresponds to the core sequence of
the CHOP AARE between
310 and
302.
CHOP AARE binds members of C/EBP and ATF protein
families in vitro.
Sequence comparison of the CHOP AARE
with database sequences did not reveal any perfect homology with known
transcription factor binding sites. However, the minimum
CHOP AARE core sequence 5'-ATTGCATCA-3' showed
some homology with binding sites of the C/EBP and ATF/CREB protein
families and was referred to as a C/EBP-ATF composite site (15,
63) (Fig. 5A). To investigate
whether DNA binding sites for C/EBP or ATF transcription factors could mediate amino acid inducibility, two copies of several candidate sites
were cloned immediately upstream of the TK promoter (see Fig. 5A for
sequences). The adenovirus E4-ATF binding site (E4 ATF) (27,
36) (Fig. 5B, row 3), a consensus C/EBP binding site (C/EBP)
(50) (row 4), the cyclic AMP response element of the
fibronectin gene (FN CRE) (45) (row 5), and a chimeric
C/EBP-CRE site (C/EBP-CRE) (50) (row 6) could not render a
basal promoter amino acid responsive. A low level of inducible promoter
activity was observed with the distal AP-1 binding site in the
c-jun gene promoter (jun2TRE) (58) (row 7), but
five copies of this binding site did not produce higher amino acid
responsiveness (data not shown). These findings demonstrate that
previously identified binding sites for ATF or C/EBP are not able to
mediate amino acid inducibility.

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 5.
Comparison of CHOP AARE with C/EBP and
ATF/CRE binding sites. (A) Sequence comparison of the CHOP
AARE ( 313 to 295) with the ATF binding site in the adenovirus E4
promoter (E4 ATF), a consensus C/EBP binding site (C/EBP), the ATF/CRE
box of the fibronectin gene promoter (FN CRE), a chimeric C/EBP-CRE
binding site (C/EBP-CRE), and the distal AP-1 binding site in the
c-jun gene promoter (jun2-TRE). The position of the minimum
AARE core sequence is boxed. Identical nucleotides are shaded in grey.
(B) HeLa cells were transfected with LUC constructs containing two
copies of the above-described sequences inserted 5' to the TK promoter.
Twenty-four hours after transfection, cells were incubated for 16 h in DMEM F12 (420 µM leucine) or in DMEM F12 lacking leucine (0 µM
leucine) and then were harvested for preparation of cell extracts and
determination of LUC activity. Relative LUC activities were determined
as described in Materials and Methods. The relative fold induction,
defined as the ratio of the relative LUC activity of leucine-starved
cells to unstarved cells, is indicated in parentheses to the right of
the bars. Each data point represents the mean of at least three
independent experiments performed in triplicate. (C) Gel mobility shift
assays of nuclear extracts from HeLa cells incubated for 16 h in
DMEM F12 in the presence of the 19-bp CHOP AARE probe. The
CHOP AARE carried sequences 313 to 295. Competing
oligonucleotides (see panel A for sequence) were added at a 25-, 50-, and 100-fold molar excess relative to the probe. The specific
DNA-protein complex is indicated by an arrow.
|
|
The results presented above do not exclude the possibility that members
of the C/EBP and ATF/CREB protein families could be involved in
the response to amino acid starvation. To determine whether
proteins binding to the CHOP AARE could be related to C/EBP
or ATF, gel mobility shift competition assays were carried out using
the DNA binding sites of these families of transcription factors as
competitors (see Fig. 5A for sequences). Oligonucleotides containing
C/EBP (Fig. 5C, lanes 5 to 7), FN CRE (lanes 8 to 10), jun2TRE (lanes
11 to 13), E4 ATF (lanes 14 to 16), and C/EBP-CRE (lanes 17 to 19)
abolished or greatly reduced the binding of the DNA-protein complex,
suggesting that proteins binding to the CHOP AARE could be
C/EBP or ATF related. To identify which members of the C/EBP and ATF
transcription factor families bind in vitro to the CHOP
AARE, gel mobility shift assays were carried out in the presence of
specific antibodies (Fig. 6). All
specific antibodies used in our experiments have been shown to
supershift protein-DNA complexes containing their corresponding
transcription factor in gel mobility shift analysis (data not shown).
As shown in Fig. 6A, antibodies against ATF-2 (lane 6) (37)
and C/EBP
(lane 10) (9) supershifted the CHOP
AARE-bound complex formed with nonstarved HeLa nuclear extracts, while
the antibodies against ATF-1 (lane 3) (21), ATF-3 (lane 4)
(11), ATF-4 (lane 5) (21), and c-Jun (lane 7)
(27) did not affect the DNA-protein complex. Furthermore,
the abundance of ATF-2 and C/EBP
supershifted DNA-protein complexes
did not vary with leucine starvation (Fig. 6B). These results show that
ATF-2 and C/EBP
transcription factors are able to bind in vitro to
the CHOP AARE sequence in the presence and absence of
leucine.

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 6.
Presence of ATF-2 and C/EBP in the DNA-protein
complex binding to the CHOP AARE. Supershift assays using
specific antibodies to different proteins and nuclear extracts from
HeLa cells incubated for 16 h in DMEM F12 (A) or DMEM F12 lacking
leucine (B). HeLa nuclear extracts were first incubated with 1 µl of
rabbit nonimmune serum or specific antiserum, and then the
preincubation mixture was incubated with the 19-bp CHOP AARE
probe as described in Materials and Methods. The 19-bp CHOP
AARE carried sequences 313 to 295.
|
|
ATF-2 has a critical role in the transcriptional activation of
CHOP by amino acids.
To assess the respective roles of
ATF-2 and C/EBP
in the transcriptional activation of CHOP
by leucine, we first measured the effect of leucine starvation on
CHOP mRNA expression in MEF deficient in ATF-2 or C/EBP
(65) and in the corresponding wild-type cells. As shown in
Fig. 7, CHOP exhibited a
normal response to leucine starvation and to an agent (tunicamycin)
that induces ER stress (31) in C/EBP
+/+
(lanes 1 to 3) and ATF-2+/+ cells (lanes 7 to 9). Lack of
C/EBP
did not affect the induction of CHOP mRNA by leucine
starvation and tunicamycin (lanes 4 to 6). By contrast, lack of ATF-2
resulted in a complete loss of the CHOP mRNA amino acid
inducibility (lanes 10 and 11) but did not affect the induction of mRNA
level by tunicamycin (lane 12). The result concerning the effect of the
ATF-2 genotype on CHOP induction was strengthened by a
kinetic analysis of the CHOP mRNA level in
ATF-2+/+ and ATF-2
/
cells exposed to medium
lacking leucine (Fig. 8A). CHOP mRNA was
only detectable in ATF-2+/+ cells 4 h after
starvation, and a maximum level was reached after 16 h. Moreover,
as shown in Fig. 8B, the defect in endogenous CHOP induction
in the ATF-2
/
cells extended to the response to
deprivation of some other amino acids (lysine, arginine, and
phenylalanine). Deprivation of these amino acids had been shown above
to increase LUC activity from the CHOP AARE LUC reporter
construct (see Fig. 3B). Taken together, these results provide evidence
that ATF-2 is essential in the specific amino acid pathway that leads
to the induction of CHOP mRNA.

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 7.
CHOP mRNA level is induced by leucine starvation in
C/EBP -deficient cells but not in ATF-2-deficient cells. Wild-type
(+/+) or mutant ( / ) C/EBP or ATF-2 MEF were incubated for
16 h in DMEM F12 (C) or in DMEM F12 lacking leucine ( L) or for
6 h in medium containing 0.125 µg of tunicamycin (+Tu)/ml. Total
RNA was extracted and Northern blot analysis was performed as described
in Materials and Methods. The blots were hybridized with human probes
corresponding to CHOP and GAPDH.
|
|

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 8.
Lack of ATF-2 results in a complete loss of amino acid
inducibility. (A) Wild-type (+/+) or mutant ( / ) MEF were incubated
in DMEM F12 (+Leu) or in DMEM F12 lacking leucine ( Leu) and were
harvested for RNA isolation after the indicated incubation times. (B)
Wild-type (+/+) or mutant ( / ) MEF were incubated for 16 h in
MEM (control) or in MEM lacking one amino acid or for 6 h in
medium containing 0.125 µg of tunicamycin (+Tu)/ml and were harvested
for RNA isolation. Northern blot analysis was performed as described in
Materials and Methods. The blots were hybridized with human probes
corresponding to CHOP and GAPDH. Quantification
of the Northern blot analysis is given graphically, below the
respective panels.
|
|
To more directly analyze the effects of ATF-2 and C/EBP
on
regulation of CHOP transcription by leucine, LUC constructs
containing either the CHOP promoter from
649 to +91 or two
copies of CHOP AARE inserted immediately upstream of the TK
promoter were transiently transfected in C/EBP
- or ATF-2-deficient
MEF and in the corresponding wild-type cells. The response to
leucine was determined by LUC assay in starved and nonstarved
conditions. Lack of C/EBP
did not significantly affect the amino
acid inducibility of these constructs (Fig.
9A), confirming that although C/EBP
binds in vitro to the CHOP AARE, this transcription factor
is not essential for the transcriptional activation of CHOP
by leucine starvation. On the other hand, lack of ATF-2 was found to
dramatically decrease the amino acid responsiveness of both LUC
constructs (Fig. 9B, bars 4 and 10). We examined the effect of an
ATF-2 dominant negative mutant on leucine-induced activity of the
CHOP promoter and the AARE. This mutant (ATF-2Ala), in
which the three SAPK phosphorylation sites (Thr-69, Thr-71, and Ser-90)
lying close to the N terminus are replaced by alanine, cannot be
phosphorylated and therefore cannot mediate transcriptional activation
(38, 49). Cotransfection of this mutant with LUC constructs
in ATF-2+/+ cells significantly inhibited the increase in
promoter activity due to leucine starvation (bars 3 and 9),
demonstrating that a dominant negative form of ATF-2 can inhibit the
stimulatory effect of leucine starvation on the AARE and promoter of
CHOP. Moreover, cotransfection of the ATF-2 expression
plasmid into ATF-2
/
cells resulted in a partial rescue
of amino acid inducibility of the CHOP promoter (bar 5) as
well as of the 2X CHOP AARE (bar 11). By contrast, in a
similar experiment cotransfection of the ATF-2Ala dominant negative
mutant was not able to rescue the amino acid inducibility (bars 6 and
12). These data demonstrate that ATF-2 expression is essential for
induction of the CHOP promoter and AARE activity by leucine
starvation, and they establish a vital role for ATF-2 in mediating
amino acid responsiveness.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 9.
ATF-2 is essential for the induction of the
CHOP promoter and AARE activity by leucine starvation. (A)
Wild-type (+/+) or mutant ( / ) C/EBP MEF were transfected with
LUC reporter constructs containing either the CHOP promoter
region from 649 to +91 [CHOP ( 649/+91)] or two copies
of the 19-bp segment of the CHOP promoter including the AARE
( 313 to 295) inserted 5' to the TK promoter (2X CHOP
AARE). (B) Wild-type (+/+) or mutant ( / ) ATF-2 MEF were
transfected with a mixture containing CHOP ( 649/+91) or
2X CHOP AARE LUC reporter constructs and a wild-type or a
dominant negative form (ATF-2Ala [50]) of ATF-2
expression plasmids. Twenty-four hours after transfection, cells were
incubated for 16 h in DMEM F12 (420 µM leucine) or in DMEM F12
lacking leucine (0 µM leucine) and then were harvested for
preparation of cell extracts and determination of LUC activity.
Relative LUC activities were determined as described in Materials and
Methods. The relative fold induction, defined as the ratio of the
relative LUC activity of leucine-starved cells to unstarved cells, is
indicated in parentheses above the bars.
|
|
 |
DISCUSSION |
The mammalian plasma concentration of free amino acids shows
striking alterations according to nutritional and pathological conditions (3, 13, 64). In recent years, evidence has
accumulated that amino acids play an important role in controlling gene
expression (30, 32). Nevertheless, the molecular mechanisms
involved in the amino acid regulation of mammalian gene expression have not been elucidated to date. The work presented in this report focuses
on the identification of the cis- and
trans-acting elements which are involved in the
transcriptional activation of CHOP in response to amino acid starvation.
The cis DNA sequence located upstream from the transcription
start site (
313 to
295) is essential for amino acid activation of
the CHOP promoter. This sequence is the first described that can regulate a basal promoter in response to starvation of several individual amino acids, in all human cell lines tested (HeLa, Caco-2,
and HepG2). This DNA element is conserved in the CHOP gene
in species other than humans, such as the hamster (46). Mutations affecting a stretch of nine nucleotides (AARE core) result in
a loss of amino acid responsiveness. From these properties, this DNA
sequence can be called an AARE. It appears that sequences outside the
AARE core could also play an important role in achieving the full amino
acid induction. Indeed, mutation mt7 outside the core
sequence (see Fig. 4A) results in a slight decrease in amino acid
inducibility, although the effect of this mutation appears to be
inhibited in mutation mt9.
Sequences of the CHOP AARE region show some homology with
the specific binding sites of the C/EBP and ATF/CREB transcription factor families (15, 63). All members of these families
contain a DNA binding domain consisting of a cluster of basic amino
acids and a leucine zipper region (b-ZIP domain) (33).
They can form homodimers or heterodimers through their leucine zipper
regions (17) and then bind to both ATF and C/EBP recognition
sites (1, 4). Depending on the composition of the
heterodimer, different sequence elements are preferentially recognized,
leading to variable transcriptional effects (10, 58). Our
present results demonstrate that although the CHOP
AARE sequence binds C/EBP
and ATF-2 in vitro, only ATF-2 has a
critical role in the transcriptional activation of CHOP by
leucine starvation. ATF-2 is capable of interacting with other b-ZIP
proteins and binding to particular recognition sequences (22, 28,
29, 50). Our data suggest that ATF-2 could bind to the
CHOP AARE as homodimer or as heterodimer with an unknown
dimerization partner. cis-acting elements which are recognized by ATF-2 in association with other known transcription factors are not able to activate transcription in response to amino
acid starvation. For example, the c-jun promoter contains two AP-1-like sites that are critical for its regulation by certain stresses and some other stimuli (2, 44, 57). In vitro
binding studies reveal that in most cells examined, proximal (jun1TRE) and distal AP-1 (jun2TRE) sites bind heterodimers composed of c-Jun and
ATF-2 (58, 59). Although the CHOP AARE shares
significant similarities with the jun2TRE (Fig. 5A), c-Jun is not able
to bind to the AARE in vitro (Fig. 6, lane 7). In addition, we
demonstrate that jun2TRE sequences do not confer amino acid
inducibility (Fig. 5B). Therefore, the association of ATF-2 and c-Jun
does not mediate the response to amino acids. Further work will be
required to determine whether another partner associated with ATF-2 is
important in the mechanism of transcriptional activation by amino acid starvation.
We do not observe differences in the AARE binding activity of ATF-2
between leucine-starved and nonstarved conditions. The transactivating
capacity of ATF-2 is activated via phosphorylation of N-terminal
residues Thr-69, Thr-71, and Ser-90 by stress-activated protein kinases
(19, 38, 59). We show that the ATF-2Ala dominant negative
mutant in which these three residues cannot be phosphorylated inhibits
full up-regulation of CHOP promoter activity induced by
leucine starvation (see Fig. 9B). Moreover, when cotransfected into
ATF-2
/
cells, this dominant negative mutant is not able
to rescue the amino acid inducibility of the CHOP promoter.
Taken together, these data suggest that the specific amino acid pathway
that leads to transcriptional activation of CHOP may involve
phosphorylation of prebound ATF-2 rather than an increase in ATF-2
binding (19).
The signaling pathways that recognize amino acid availability in
mammalian cells have not been investigated as extensively as those in
bacteria or yeast. We show that ATF-2 is essential in the amino acid
pathway that leads to the induction of CHOP mRNA and confirm
that this specific pathway is independent of the unfolded protein
response. ATF-2 has been shown to be ubiquitously expressed, with the
highest level of expression being observed in the brain
(52), but the physiological role of ATF-2 remains poorly
understood. Knockout mice generated by gene targeting exhibited lowered
postnatal viability and growth, with a severe respiratory distress
(39) or with a defect in endochondral ossification and a
reduced number of cerebellar Purkinje cells (47). The data
presented in this paper suggest that modulation of ATF-2 activity could
also play an important role in the process of defense or adaptation to
amino acid limitation that occurs in nutritional or pathological conditions.
The concept that amino acids can regulate gene expression has just
started to emerge. It is now clear that amino acids can play an
important role in the control of gene expression in concert with
hormones. However, the underlying mechanisms have only begun to be
discovered. Our results show that the transcriptional activity of ATF-2
is essential for the regulation of CHOP expression by amino
acids. The physiological meaning of CHOP regulation by amino acids is not yet understood. Through its interaction with C/EBP transcription factors, CHOP may participate in the regulation of
several mechanisms (43) during cellular response to amino acid limitation. For example, CHOP could play a crucial role in the regulation of nitrogen metabolism under amino acid control, although a direct role for CHOP in this pathway has yet to be demonstrated. During a cellular stress that perturbs function of the
endoplasmic reticulum (ER stress), CHOP expression, in concert with a second signal, was found to be absolutely required for
the activation of a set of previously undescribed genes referred to as
DOCs (for downstream of CHOP) (62). We have
hypothesized that CHOP may also mediate the induction of cellular DOC
genes in the context of the amino acid response, but the identification of such genes remains to be done.
Defining the precise cascade of molecular events by which the cellular
concentration of an individual amino acid regulates gene expression
will be an important contribution to our understanding of metabolite
control in mammalian cells. These studies will provide insight into the
role of amino acids in the regulation of cellular functions like cell
division, protein synthesis, and proteolysis.
 |
ACKNOWLEDGMENTS |
We are grateful to S. Ishii for the ATF-2 and ATF-2Ala expression
plasmids and to U. Schiebler for providing anti-C/EBP
serum. We
thank V. Poli and D. Ron for the gift of the C/EBP
-deficient MEF. We
also thank D. Ron for the anti-ATF-4 serum.
This work was supported by grants from the Institut National de la
Recherche Agronomique, the Fondation pour la Recherche Médicale,
and the Arthritis Foundation (A.M.R.). C. Jousse is a recipient of a
French M.E.N.S.R. predoctoral scholarship and a DANONE research scholarship.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: U.R. 238 de
Nutrition Cellulaire et Moléculaire, INRA de Theix, 63122 Saint
Genès Champanelle, France. Phone: 33 4 73 62 45 62. Fax: 33 4 73 62 45 70. E-mail: fpierre{at}clermont.inra.fr.
 |
REFERENCES |
| 1.
|
Alonso, C. R.,
C. G. Pesce, and A. R. Kornblihtt.
1996.
The CCAAT-binding proteins CP1 and NF-1 cooperate with ATF-2 in the transcription of the fibronectin gene.
J. Biol. Chem.
271:22271-22279[Abstract/Free Full Text].
|
| 2.
|
Angel, P.,
M. Imagawa,
R. Chiu,
B. Stein,
R. J. Imbra,
H. J. Ramsdorf,
P. Herrlich, and M. Karin.
1987.
Phorbol ester-inducible genes contain a common cis-acting element recognized by a TPA-modulated trans-acting factor.
Cell
49:729-739[CrossRef][Medline].
|
| 3.
|
Baertl, J. M.,
R. P. Placko, and G. G. Graham.
1974.
Serum proteins and plasma free amino acids in severe malnutrition.
Am. J. Clin. Nutr.
27:733-742[Abstract].
|
| 4.
|
Bakker, O., and M. G. Parker.
1991.
CAAT/enhancer binding protein is able to bind to ATF/CRE elements.
Nucleic Acids Res.
19:1213-1217[Abstract/Free Full Text].
|
| 5.
|
Barone, M. V.,
A. Y. Crozat,
A. Tabaee,
L. Philipson, and D. Ron.
1994.
CHOP (GADD153) and its oncogenic variant, TLS-CHOP, have opposing effects on the induction of G1/S arrest.
Genes Dev.
8:453-464[Abstract/Free Full Text].
|
| 6.
|
Batchvarova, N.,
X. Z. Wang, and D. Ron.
1995.
Inhibition of adipogenesis by the stress-induced protein CHOP.
EMBO J.
14:4654-4661[Medline].
|
| 7.
|
Birkenmeier, E. H.,
B. Gwynn,
S. Howard,
J. Jerry,
J. I. Gordon,
W. H. Landschulz, and S. L. McKnight.
1989.
Tissue-specific expression, developmental regulation, and genetic mapping of the gene encoding CCAAT/enhancer binding protein.
Genes Dev.
3:1146-1156[Abstract/Free Full Text].
|
| 8.
|
Bruhat, A.,
C. Jousse,
X.-Z. Wang,
D. Ron,
M. Ferrara, and P. Fafournoux.
1997.
Amino acid limitation induces expression of CHOP, a CCAAT/enhancer binding protein-related gene, at both transcriptional and post-transcriptional levels.
J. Biol. Chem.
272:17588-17593[Abstract/Free Full Text].
|
| 9.
|
Cao, Z.,
R. M. Umek, and S. L. McKnight.
1991.
Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells.
Genes Dev.
5:1538-1552[Abstract/Free Full Text].
|
| 10.
|
Chatton, B.,
J. L. Bocco,
J. Goetz,
M. Gaire,
Y. Lutz, and C. Kedinger.
1994.
Jun and Fos heterodimerize with ATFa, a member of the ATF/CREB family, and modulate its transcriptional activity.
Oncogene
9:375-385[Medline].
|
| 11.
|
Chen, B. P. C.,
C. D. Wolfgang, and T. Hai.
1996.
Analysis of ATF3, a transcription factor induced by physiological stresses and modulated by gadd153/Chop10.
Mol. Cell. Biol.
16:1157-1168[Abstract].
|
| 12.
|
Chomczynski, P., and N. Sacchi.
1987.
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
Anal. Biochem.
162:156-159[Medline].
|
| 13.
|
Fafournoux, P.,
C. Remesy, and C. Demigné.
1990.
Fluxes and membrane transport of amino acids in rat liver under different protein diets.
Am. J. Physiol.
259:E614-E625[Abstract/Free Full Text].
|
| 14.
|
Fawcett, T. W.,
H. B. Eastman,
J. L. Martindale, and N. J. Holbrook.
1996.
Physical and functional association between GADD153 and CCAAT/enhancer-binding protein during cellular stress.
J. Biol. Chem.
271:14285-14289[Abstract/Free Full Text].
|
| 15.
|
Fawcett, T. W.,
J. L. Martindale,
K. Z. Guyton,
T. Hai, and N. J. Holbrook.
1999.
Complexes containing activating transcription (ATF)/cAMP-responsive-element-binding protein (CREB) interact with the CCAAT/enhancer-binding protein (C/EBP)-ATF composite site to regulate Gadd153 expression during the stress response.
Biochem. J.
339:135-141.
|
| 16.
|
Girard, J.,
D. Perdereau,
F. Foufelle,
C. Prip-Buus, and P. Ferré.
1994.
Regulation of lipogenic enzyme gene expression by nutrients and hormones.
FASEB J.
8:36-42[Abstract].
|
| 17.
|
Göttlicher, M.,
S. Heck, and P. Herrlich.
1998.
Transcriptional cross-talk, the second mode of steroid hormone receptor action.
J. Mol. Med.
76:480-489[CrossRef][Medline].
|
| 18.
|
Guerrini, L.,
S. S. Gong,
K. Mangasarian, and C. Basilico.
1993.
cis- and trans-acting elements involved in amino acid regulation of asparagine synthetase gene expression.
Mol. Cell. Biol.
13:3202-3212[Abstract/Free Full Text].
|
| 19.
|
Gupta, S.,
D. Campbell,
B. Dérijard, and R. J. Davis.
1995.
Transcription factor ATF2 regulation by the JNK signal transduction pathway.
Science
267:389-393[Abstract/Free Full Text].
|
| 20.
|
Gurney, A. L.,
E. A. Pak,
J. Liu,
M. Giralt,
M. M. McGrane,
Y. M. Patel,
D. R. Crawford,
S. E. Nizielski,
S. Savon, and R. W. Hanson.
1994.
Metabolic regulation of gene transcription.
J. Nutr.
124:1533S-1539S.
|
| 21.
|
Hai, T.,
F. Liu,
W. J. Coukos, and M. R. Green.
1989.
Transcription factor ATF cDNA clones: an extensive family of leucine zipper proteins able to selectively form DNA-binding hetero-dimers.
Genes Dev.
3:2083-2090[Abstract/Free Full Text].
|
| 22.
|
Hai, T., and T. Curran.
1991.
Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity.
Proc. Natl. Acad. Sci. USA
88:3720-3724[Abstract/Free Full Text].
|
| 23.
|
Hall, C. V.,
P. E. Jacob,
M. Ringold, and F. Lee.
1983.
Expression and regulation of Escherichia coli lacZ gene fusions in mammalian cells.
J. Mol. Appl. Genet.
2:101-109[Medline].
|
| 24.
|
Hinnebusch, A. G.
1988.
Mechanisms of gene regulation in the general control of amino acid biosynthesis in Saccharomyces cerevisiae.
Microbiol. Rev.
52:248-273[Free Full Text].
|
| 25.
|
Hinnebusch, A. G.
1994.
Translational control of GCN4: an in vivo barometer of initiation-factor activity.
Trends Biochem. Sci.
19:409-414[CrossRef][Medline].
|
| 26.
|
Hope, I. A., and K. Struhl.
1985.
GCN4 protein, synthesized in vitro, binds HIS3 regulatory sequences: implications for general control of amino acid biosynthetic genes in yeast.
Cell
43:177-188[CrossRef][Medline].
|
| 27.
|
Hurst, H. C., and N. C. Jones.
1987.
Identification of factors that interact with E1A-inducible adenovirus E3 promoter.
Genes Dev.
1:1132-1146[Abstract/Free Full Text].
|
| 28.
|
Ivashkiv, L. B.,
H. C. Liou,
C. J. Kara,
W. W. Lamph,
I. M. Verma, and L. H. Glimcher.
1990.
MXBP/CRE-BP2 and c-jun form a complex which binds to the cyclic AMP, but not the 12-O-tetracanoylphorbol-13-acetate, response element.
Mol. Cell. Biol.
10:1609-1621[Abstract/Free Full Text].
|
| 29.
|
Ivashkiv, L. B.,
M. D. Fleming, and L. H. Glimcher.
1992.
Dominant negative mutants of transcription factor mXBP (CRE-BP1, ATF2).
New Biol.
4:360-368[Medline].
|
| 30.
|
Jousse, C.,
A. Bruhat,
M. Ferrara, and P. Fafournoux.
1998.
Physiological concentration of amino acids regulates insulin-like-growth-factor-binding protein 1 expression.
Biochem. J.
334:147-153.
|
| 31.
|
Jousse, C.,
A. Bruhat,
H. P. Hardind,
M. Ferrara,
D. Ron, and P. Fafournoux.
1999.
Amino acid limitation induces CHOP through a specific pathway independent on the unfolded protein response.
FEBS Lett.
448:211-216[CrossRef][Medline].
|
| 32.
|
Jousse, C.,
A. Bruhat, and P. Fafournoux.
1999.
Amino acid regulation of gene expression.
Curr. Opin. Clin. Nutr. Metab. Care
2:297-301[CrossRef][Medline].
|
| 33.
|
Karin, M., and T. Smeal.
1992.
Control of transcription factors by signal transduction pathways: the beginning of the end.
Trends Biochem. Sci.
17:418-422[CrossRef][Medline].
|
| 34.
|
Kilberg, M. S.,
B. R. Stevens, and D. A. Novak.
1993.
Recent advances in mammalian amino acid transport.
Annu. Rev. Nutr.
13:137-165[CrossRef][Medline].
|
| 35.
|
Kilberg, M. S.,
R. G. Huston, and R. O. Laine.
1994.
Amino acid-regulated gene expression in eukaryotic cells.
FASEB J.
8:13-18[Abstract].
|
| 36.
|
Lin, Y. S., and M. R. Green.
1988.
Interaction of a common cellular transcription factor, ATF, with regulatory elements in both E1a- and cyclic AMP-inducible promoters.
Proc. Natl. Acad. Sci. USA
85:3396-3400[Abstract/Free Full Text].
|
| 37.
|
Liu, F., and M. R. Green.
1990.
A specific member of the ATF transcription factor family can mediate transcription activation by the adenovirus E1A protein.
Cell
61:1217-1224[CrossRef][Medline].
|
| 38.
|
Livingstone, C.,
G. Patel, and N. Jones.
1995.
ATF-2 contains a phosphorylation-dependent transcriptional activation domain.
EMBO J.
14:1785-1797[Medline].
|
| 39.
|
Maekawa, T.,
F. Bernier,
M. Sato,
S. Nomura,
M. Singh,
Y. Inoue,
T. Tokunaga,
H. Imai,
M. Yokoyama,
A. M. Reimold,
L. Glimcher, and S. Ishii.
1999.
Mouse ATF-2 null mutants display features of a severe type of meconium aspiration syndrome.
J. Biol. Chem.
274:17813-17819[Abstract/Free Full Text].
|
| 40.
|
Marten, N. W.,
E. J. M. Burke,
J. Hayden, and D. S. Straus.
1994.
Effect of amino acid limitation on the expression of 19 genes in rat hepatoma cells.
FASEB J.
8:538-544[Abstract].
|
| 41.
|
Matsuda, S.,
T. Maekawa, and S. Ishii.
1991.
Identification of the functional domains of the transcriptional regulator CRE-BP1.
J. Biol. Chem.
266:18188-18193[Abstract/Free Full Text].
|
| 42.
|
McGivan, J. D., and M. Pastor-Anglada.
1994.
Regulatory and molecular aspects of mammalian amino acid transport.
Biochem. J.
299:321-334.
|
| 43.
|
McKnight, S.,
M. D. Lane, and S. Gluecksohn-Waelsch.
1989.
Is CCAAT/enhancer-binding protein a central regulator of energy metabolism?
Genes Dev.
3:2021-2024[Free Full Text].
|
| 44.
|
Muegge, K.,
M. Vila,
G. L. Gusella,
T. Musso,
P. Herrlich,
B. Stein, and S. K. Durum.
1993.
Interleukin 1 induction of the c-jun promoter.
Proc. Natl. Acad. Sci. USA
90:7054-7058[Abstract/Free Full Text].
|
| 45.
|
Muro, A. F.,
V. A. Bernath, and A. R. Kornblihtt.
1992.
Interaction of the 170 cyclic AMP response element with the adjacent CCAAT box in the human fibronectin gene promoter.
J. Biol. Chem.
267:12767-12774[Abstract/Free Full Text].
|
| 46.
|
Park, J. S.,
J. D. Luethy,
M. G. Wang,
J. Fargnoli,
A. J. Fornace, Jr.,
O. W. McBride, and N. J. Holbrook.
1992.
Isolation, characterization and chromosomal localization of the human GADD153 gene.
Gene
116:259-267[CrossRef][Medline].
|
| 47.
|
Reimold, A. M.,
M. J. Grusby,
B. Kosaras,
J. W. U. Fries,
R. Mory,
S. Maniwa,
I. M. Clauss,
T. Collins,
R. L. Sidman,
M. J. Glimcher, and L. H. Glimcher.
1996.
Chondrodysplasia and neurological abnormalities in ATF-2 deficient mice.
Nature
379:262-265[CrossRef][Medline].
|
| 48.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed., p. 7.46.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 49.
|
Sano, Y.,
J. Harada,
S. Tashiro,
R. Gotoh-Mandeville,
T. Maekawa, and S. Ishii.
1999.
ATF-2 is a common nuclear target of Smad and TAK1 pathways in transforming growth factor- signaling.
J. Biol. Chem.
274:8949-8957[Abstract/Free Full Text].
|
| 50.
|
Shuman, J. D.,
J. Cheong, and J. E. Coligan.
1997.
ATF-2 and C/EBP can form a heterodimeric DNA binding complex in vitro.
J. Biol. Chem.
272:12793-12800[Abstract/Free Full Text].
|
| 51.
|
Sok, J.,
X.-Z. Wang,
N. Batchvarova,
M. Kuroda,
H. Harding, and D. Ron.
1999.
CHOP-dependent stress-inducible expression of a novel form of carbonic anhydrase VI.
Mol. Cell. Biol.
19:495-504[Abstract/Free Full Text].
|
| 52.
|
Takeda, J.,
T. Maekawa,
T. Sudo,
Y. Seino,
H. Imura,
N. Sato,
C. Tanaka, and S. Ishii.
1991.
Expression of CRE-BP1 transcriptional regulator binding to cyclic AMP response element in central nervous system, regenerating liver and human tumors.
Oncogene
6:1009-1014[Medline].
|
| 53.
|
Todaro, G. J., and H. Green.
1963.
Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines.
J. Cell Biol.
17:299-313[Abstract/Free Full Text].
|
| 54.
|
Towle, H. C.
1995.
Metabolic regulation of gene transcription in mammals.
J. Biol. Chem.
270:23235-23238[Free Full Text].
|
| 55.
|
Ubeda, M.,
X.-Z. Wang,
H. Zinszner,
I. Wu,
J. F. Habener, and D. Ron.
1996.
Stress-induced binding of the transcription factor CHOP to a novel DNA control element.
Mol. Cell. Biol.
16:1479-1489[Abstract].
|
| 56.
|
Umek, R. M.,
A. D. Friedman, and S. L. McKnight.
1991.
CCAAT-enhancer binding protein: a component of a differentiation switch.
Science
251:288-292[Abstract/Free Full Text].
|
| 57.
|
Van Dam, H.,
R. Offringa,
I. Meijer,
B. Stein,
A. M. Smits,
P. Herrlich,
J. L. Bos, and A. J. van der Eb.
1990.
Differential effects of the adenovirus E1A oncogene on members of the AP-1 transcription factor family.
Mol. Cell. Biol.
10:5857-5864[Abstract/Free Full Text].
|
| 58.
|
Van Dam, H.,
M. Duyndam,
R. Rottier,
A. Bosch,
L. de Vries-Smits,
P. Herrlich,
A. Zantema,
P. Angel, and A. J. van der Eb.
1993.
Heterodimer formation of cJun and ATF-2 is respo |